Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors. - Wikidata - awgldk - TriplyDB

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

http://www.wikidata.org/entity/Q33710298

about

Cardiovascular rehabilitation, ballroom dancing and sexual dysfunction Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells.How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.The endothelial cell in health and disease: its function, dysfunction, measurement and therapy.How can heart failure patients and their partners be counseled on sexual activity?Sexual dysfunction in heart failure patients.Sexual activity: an exercise to prevent cardiovascular morbidity and mortality?

P2860

Q33933321-B2D1016B-30B1-491F-8BD3-8948DCB7A296 Q34357737-A013083F-5ABC-411E-AB06-CE275724D967 Q37582767-3C064DD1-931B-4D0B-B1FE-4383ECC0DB10 Q37662195-61B58E35-B57E-4A34-94D9-2238B4A3B86B Q38105997-3CD4ED80-868E-4AB3-BA0A-3B1FF6184750 Q38209723-E2ACC255-4156-4065-B846-C33508503D10 Q44877883-32C7E67A-8CE4-4C8B-A31A-556D90CC92CE

P2860

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

http://www.wikidata.org/entity/Q33710298

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

@ast

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

@en

type

label

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

@ast

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

@en

prefLabel

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

@ast

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

@en

P1433

Q33710298-6532B362-A39C-491D-AA11-2C1C0E5A1538

P1476

Q33710298-5613CBC3-DDDF-48E1-A48A-319EC8792BCA

P2093

Q33710298-7C96F299-867E-452C-8EB5-83EC8CA1C1CB

Q33710298-D021ABCD-DE08-4A49-9B9B-FA0870C557BA

P275

Q33710298-24A04C48-CD20-4670-B60D-CDA2CB9F46FD

P2860

Q33710298-02D0D79E-BF26-4122-BDC6-36BBBFFAE226

Q33710298-03D91EB2-C834-4B96-8BA6-9AD9DE58E8A0

Q33710298-0B7444A8-4314-455B-9263-7727760E39E3

Q33710298-1282ECEC-59BC-4F19-84E5-6DA9033275D8

Q33710298-16AC8609-B6D5-4B32-BBFD-843814144225

Q33710298-1ADC76ED-ED9D-408F-9728-0FCD3AD400A4

Q33710298-22E68144-1B35-4070-8BCC-085E7E5F4B50

Q33710298-24D45E0A-8E6C-4880-A10A-49C07041DEFF

Q33710298-2A92A0BC-A43E-41AC-867F-A183C9B9F56C

Q33710298-2B9CAEDB-CCE0-44C4-AE7E-3D3366861110

P2888

Q33710298-42120A71-B231-4875-8743-1F1C7E136232

P304

Q33710298-FC047C0D-FB18-4946-91F5-80B473CB06BD

P31

Q33710298-3F035FAD-CB52-4F86-B042-9E5FAE8D6B94

Q33710298-9B1126DE-3A17-4A35-8BCA-25E07C63F15A

P356

Q33710298-C412761C-53A4-4970-AB63-C96BF19B78F6

P433

Q33710298-F52784B9-1AC3-43F2-B701-D9FE507BCBC7

P478

Q33710298-E17F2460-EC43-4037-8549-08AD77A9D010

P5008

Q33710298-1EF4BB54-3EF4-4567-9E62-300E52B31930

P577

Q33710298-6493A643-4AE2-4DB1-B459-F7051FD29444

P5875

Q33710298-D544FAB2-CB4E-49B5-B33C-93307DD2A2C3

P6179

Q33710298-86B66CFD-D4DC-4D1D-98E9-9D454C604A43

P698

Q33710298-1B157643-7048-4E12-9056-A81372FC3704

P921

Q33710298-073EFEDC-284F-4F4D-B579-DAC57EAC2CF8

Q33710298-402099E5-6F1C-49BB-8617-A6A97333B908

Q33710298-8892BEF8-39E9-4144-8FB4-123BC8EDE1A9

Q33710298-C889817B-3CBD-46FE-892E-E90EC7C88C32

P932

Q33710298-0F27E876-16D7-470E-ABE9-F7D2CCB90B85

P356

P1433

International Journal of Impotence Research

P1476

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

@en

P2093

H Al-Ameri

http://www.w3.org/2001/XMLSchema#string

R A Kloner

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.

Erectile dysfunction.

The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction.

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure.

P2888

P304

149-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/IJIR.2009.11

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2009-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24350777

http://www.w3.org/2001/XMLSchema#string

P6179

1028554540

http://www.w3.org/2001/XMLSchema#string

P698

19387454

http://www.w3.org/2001/XMLSchema#string

P921

erectile dysfunction

mechanism of action

physiological sexual dysfunction

P932

2834326

http://www.w3.org/2001/XMLSchema#string